APHA was my #1 Cannabis play going into this year based on the fundamentals and it's held up very well, still my #1 long term pick today (along with tangential Cannabis play IIPR).
That was followed by CGC and ACB with TLRY coming in at #4. Now with my #1 and and #4 plays merging and largely rounding out their strengths and weaknesses, it is an even stronger #1 by a factor of 1, maybe 2 over each CGC and ACB.
Amazingly, TLRY is still dirt cheap sitting at 3% of it's $300 peak a year ago lol.
Price is even UNDER its IPO and BELOW its Value Channel here (magenta). Seems impossible it goes under $2 now so max temporary downside is very constrained.
TLRY now the Best Value Cannabis Stock out there supplanting long reigning champ OGI, which is my #5 play overall but quite underpriced ATM relative to the market.
I'm lookin to scale in most my position before $21 and watching it float up like smoke!
That was followed by CGC and ACB with TLRY coming in at #4. Now with my #1 and and #4 plays merging and largely rounding out their strengths and weaknesses, it is an even stronger #1 by a factor of 1, maybe 2 over each CGC and ACB.
Amazingly, TLRY is still dirt cheap sitting at 3% of it's $300 peak a year ago lol.
Price is even UNDER its IPO and BELOW its Value Channel here (magenta). Seems impossible it goes under $2 now so max temporary downside is very constrained.
TLRY now the Best Value Cannabis Stock out there supplanting long reigning champ OGI, which is my #5 play overall but quite underpriced ATM relative to the market.
I'm lookin to scale in most my position before $21 and watching it float up like smoke!
Note
Would you look at that... nailed my line lol... Still in Value Channel people! Will load up more if lookin like we're gonna finally breakout but lotta ifs in the pipeline this week, gotta take it a day at a time.
Data analyst with a passion for best fit lines B)
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Data analyst with a passion for best fit lines B)
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.